BioPorto

BioPorto A/S, an in-vitro diagnostics company, provides diagnostic tests and antibodies to clinicians and researchers worldwide. The company offers the neutrophil gelatinase-associated lipocalin test, a particle-enhanced turbidimetric test that measures NGAL that is used to supplement clinical evaluation and standard tests; monoclonal antibodies for scientific, pharmaceutical, and clinical research use; enzyme-linked immunosorbent assay kits; IVD automated assays; and generic rapid assay device platform for the development of lateral flow assays. Show More...

  • Website https://bioporto.com
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Last Quote 1.41 DKK
  • Last Updated 28-05-2025
  • External Links Yahoo Finance Morningstar Ratios
  •   2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM
    Earnings Per Share DKK -0.25 -0.25 -0.24 -0.28 -0.11 -0.09 -0.17 -0.22 -0.24 -0.4 -0.39
    Dividends DKK
    Payout Ratio % *
    Shares Mil 57.0 58.0 61.0 80.0 120.0 124.0 133.0 147.0 159.0 173.0 175.0
    Book Value Per Share * DKK 0.14 0.13 -0.12 0.39 0.27 0.35 0.19 0.13 0.16 0.23 0.05
    Free Cash Flow Per Share * DKK -0.24 -0.2 -0.25 -0.15 -0.11 -0.12 -0.17 -0.19 -0.24 -0.3
    Return on Assets % -68.98 -70.28 -74.56 -58.91 -29.02 -24.89 -45.77 -55.47 -57.73 -127.92 -166.66
    Financial Leverage (Average) 6.34 5.39 1.21 1.3 1.1 1.14 1.17 1.17 1.69 2.56
    Return on Equity % -151.78 -409.38 -98.88 -36.13 -29.33 -51.37 -64.26 -67.78 -170.86 -269.78
    Return on Invested Capital % -52.77 -66.18 -82.51 -69.37 -36.48 -28.84 -51.35 -64.2 -67.76 -156.08 -254.23
    Interest Coverage -14.98 -6.25 -7.77 -12.06 -45.65 -857.59 -226.75 -191.75
    Current Ratio 3.52 4.03 0.92 5.78 4.23 10.65 9.24 7.28 6.8 2.32 1.33
    Quick Ratio 2.92 3.32 0.63 5.23 3.5 9.22 8.06 6.32 6.01 1.64 0.59
    Debt/Equity 3.6 3.09 0.06 0.09